Clinical Trial Update: A Phase 1 Study To Evaluate the Safety of Migalastat Hydrochloride Given Intravenously to Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety of intravenous migalastat hydrochloride in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• Migalastat hydrochloride (migalastat hydrochloride)

Snippet

Sponsor: Amicus Therapeutics | Conditions: Fabry Disease | Phase 1 | Status: COMPLETED